Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 July 2013 09:29
Malaria parasites thrive in red blood cells
The quest for a malaria vaccine has moved a step further after an Australian trial proved successful on mice.
The vaccine caused naturally existing white cells, or T-cells, to attack the potentially deadly malaria parasite that lives in red blood cells.
This is encouraging news for travellers, who need to be particularly wary if visiting a country where the disease is present. Those travelling to such countries should remember to arrange medical travel insurance before leaving home.
Scientists from Queensland's Griffith University reported that a single vaccination led to immunity to different malaria parasite species.
Lead author Professor Michael Good said the team's research, published in the Journal of Clinical Investigation, was focused on inducing the white blood cells to attack the parasite, whatever the malaria strain.
"The T-cells, when they're induced to kill malaria, can recognise proteins throughout the parasite, even internal proteins in the parasite," he said.
"So that's where we think the novel aspect is. We've been able to induce a form of immune response which can recognise molecules in the parasite which are present in every single strain."
Prof Good said he believed it was the first time a vaccine had been shown to protect against more than two strains of malaria in mice.
The vaccine is expected to be cheap and easy to manufacture, so if it works on humans it could have a significant impact in poor countries where malaria kills thousands of people every year.
"But we don't want to get ahead of ourselves," Prof Good cautioned. "We want to demonstrate, first and foremost, that the vaccine is effective in humans."
In 2010 an estimated 219 million people were infected with the disease and around 660,000 died, most of them African children under the age of five, the World Health Organisation said.
A study published in the Lancet in February 2012 said the global death toll was more likely to be around 1.2 million a year.
19 April 2018
A self-injected smart drug may be the key to easing and preventing pain for migraine sufferers.
[more...]
17 April 2018
Despite its reputation as a party drug, ketamine is licensed as an anaesthetic. A recent US study found use of the drug via a nasal spray led to "significant" improvements in depressive symptoms in the first 24 hours.
Simple brain-training exercises carried out at home have been shown to reduce emotional stress in female breast cancer survivors, it's recently been revealed.
13 April 2018
Drinkers who consume more alcohol than UK guidelines suggest could be cutting years off their lives, according to new research.
12 April 2018
A recent study has revealed that people who sustain brain injuries are at an increased risk of developing dementia later in life.
11 April 2018
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
07 April 2018
The Philippines is set to shut its most famous holiday island of Boracay for six months, after the President described it as a "cesspool".
05 April 2018
Taxes on soft drinks, alcohol and tobacco - nicknamed "sin taxes" - could be a powerful step towards combating rising rates of chronic diseases worldwide, research has suggested.
New "one-stop shops" to speed up cancer diagnosis are being trialled across the country for the first time.
30 March 2018
Doctors should tell patients that e-cigarettes are less harmful than smoking but not without risk, according to new national guidance.
29 March 2018
Young people suffering from mental health problems are finding it hard to get the support they need, a survey has revealed.
28 March 2018
Children exposed to epilepsy drugs in the womb may achieve poorer test results at school, a study has suggested.